We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
+4.65%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$2.61B
AUM Growth
+$250M
(+11%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
45.81%
Holding
1,510
New
336
Increased
390
Reduced
392
Closed
367
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.24% |
| 2 | Healthcare | 10.61% |
| 3 | Industrials | 10.3% |
| 4 | Consumer Discretionary | 7.12% |
| 5 | Financials | 4.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NLSN
351
DELISTED
Nielsen Holdings plc
NLSN
| $714K | 0.03% |
14,754
-5,243
| -26% | -$244K |
|
352
Bio-Rad Laboratories Class A
BIO
$9.42B
| $712K | 0.03% |
5,950
+300
| +5% | +$36.6K |
|
353
Henry Schein
HSIC
$9.82B
| $712K | 0.03% |
15,300
+4,335
| +40% | +$198K |
|
354
Patterson-UTI
PTEN
$3.76B
| $710K | 0.03% |
20,317
-300
| -1% | -$9.85K |
|
|
CMLS
355
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $710K | 0.03% |
13,464
-1,041
| -7% | -$54.3K |
|
356
Archrock
AROC
$5.8B
| $706K | 0.03% |
15,700
-6,021
| -28% | -$260K |
|
|
OUTR
357
DELISTED
OUTERWALL INC
OUTR
| $706K | 0.03% |
11,900
+2,500
| +27% | +$169K |
|
|
FNSR
358
DELISTED
Finisar Corp
FNSR
| $703K | 0.03% |
+35,600
| New | +$856K |
|
359
ScottsMiracle-Gro
SMG
$3.66B
| $701K | 0.03% |
12,322
+3,782
| +44% | +$226K |
|
|
ITG
360
DELISTED
Investment Technology Group Inc
ITG
| $700K | 0.03% |
41,475
-4,400
| -10% | -$83.2K |
|
361
Saic
SAIC
$5.35B
| $699K | 0.03% |
+15,836
| New | +$625K |
|
362
Karyopharm Therapeutics
KPTI
$48M
| $698K | 0.03% |
+1,000
| New | +$465K |
|
363
OGE Energy
OGE
$9.71B
| $694K | 0.03% |
17,767
-1,420
| -7% | -$52K |
|
|
ESI
364
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $694K | 0.03% |
41,600
+23,600
| +131% | +$538K |
|
|
CTRX
365
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $692K | 0.03% |
15,662
+8,946
| +133% | +$379K |
|
366
NCR Voyix
VYX
$1.14B
| $691K | 0.03% |
32,075
+13,273
| +71% | +$268K |
|
367
IQVIA
IQV
$39.3B
| $690K | 0.03% |
12,942
-4,974
| -28% | -$251K |
|
368
Immunic
IMUX
$195M
| $689K | 0.03% |
+63
| New | +$442K |
|
369
Prothena Corp
PRTA
$450M
| $689K | 0.03% |
+30,549
| New | +$764K |
|
370
ABM Industries
ABM
$2.84B
| $686K | 0.03% |
25,411
+9,328
| +58% | +$253K |
|
371
Ryman Hospitality Properties
RHP
$7.63B
| $686K | 0.03% |
14,241
+1,995
| +16% | +$91.7K |
|
372
Old National Bancorp
ONB
$10.2B
| $681K | 0.03% |
47,700
-6,346
| -12% | -$89.2K |
|
373
Cabot Corp
CBT
$4.52B
| $680K | 0.03% |
11,726
+3,495
| +42% | +$204K |
|
374
Globus Medical
GMED
$11.2B
| $675K | 0.03% |
+28,222
| New | +$681K |
|
375
Capri Holdings
CPRI
$1.74B
| $671K | 0.03% |
7,564
+3,000
| +66% | +$276K |
|
Similar funds
SCP
Tudor Investment Corp's Q2 2014 Portfolio in Review
As of Q2 2014, Tudor Investment Corp held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Tudor Investment Corp deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.1% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Tudor Investment Corp's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Tudor Investment Corp added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Tudor Investment Corp's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Tudor Investment Corp fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Tudor Investment Corp's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Tudor Investment Corp opened 336 new positions and closed 367 in Q2 2014.
- Tudor Investment Corp's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.